Gina Kolata

New York

Medical Reporter at The New York Times

Medical reporter for the New York Times and author of six books. The latest, Mercies in Disguise, will be published in March of 2017.

Featured in: Favicon

nytimes.com Favicon

uol.com.br (+2) Favicon

msn.com

globo.com (+1) Favicon

estadao.com.br Favicon

indiatimes.com (+2) Favicon

huffpost.com Favicon

r7.com

terra.com.br Favicon

independent.co.uk + 96 more

Articles

Harvard president battles Trump but agrees campus culture needs change

1 week ago | straitstimes.com | Gina Kolata |Jeremy Peters

WASHINGTON - Dr Alan Garber, president of Harvard University, disagrees with President Donald Trump about many things. He is fighting Mr Trump as the federal government tries to strip Harvard of billions of dollars in research funding and its non-profit tax status. But Dr Garber agrees with Mr Trump on one point.
What nearly brainless rodents know about weight loss and hunger

1 week ago | texarkanagazette.com | Gina Kolata

Do we really have free will when it comes to eating? It's a vexing question that is at the heart of why so many people find it so difficult to stick to a diet. To get answers, neuroscientist Harvey J. Grill of the University of Pennsylvania turned to rats and asked what would happen if he removed all of their brains except their brainstems. The brainstem controls basic functions like heart rate and breathing. But the animals could not smell, could not see, could not remember.
Lecciones sobre el hambre que nos enseĆ±an roedores casi sin cerebro

1 week ago | nytimes.com | Gina Kolata

Varias investigaciones iniciadas hace décadas siguen sorprendiendo a los científicos y subrayan que la sensación de saciedad de los animales no tiene nada que ver con la conciencia. ¿De verdad tenemos libre albedrío a la hora de comer? Se trata de una pregunta enigmática que es la clave de las razones por las que a tanta gente le resulta tan difícil seguir una dieta. Para obtener respuestas, el neurocientífico Harvey J.
Harvard's President Alan Garber Talks About His Legal Fight With Trump

1 week ago | nytimes.com | Gina Kolata |Jeremy Peters

Alan Garber became a hero to liberals after Harvard resisted the federal government. At the same time, he is trying to remake campus culture in ways the Trump administration might appreciate. Dr. Alan Garber, president of Harvard, disagrees with President Trump about many things. He is fighting Mr. Trump as the federal government tries to strip Harvard of billions of dollars in research funding and its nonprofit tax status. But Dr. Garber agrees with Mr. Trump on one point.
What nearly brainless rodents know about weight loss and hunger

1 week ago | nzherald.co.nz | Gina Kolata

Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop. Photo / Josh Norem, The New York TimesTHREE KEY FACTSNeuroscientists found that eating is largely controlled by automatic brain processes, not conscious decisions. Research shows the brain assesses caloric content through sight, taste, and gut signals to regulate eating. New discoveries about hunger neurons may lead to more effective obesity treatments with fewer side effects.
Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies

2 weeks ago | nytimes.com | Gina Kolata

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an immunotherapy trial offered stunning results. When a person develops solid tumors in the stomach or esophagus or rectum, oncologists know how to treat them. But the cures often come with severe effects on quality of life. That can include removal of the stomach or bladder, a permanent colostomy bag, radiation that makes patients infertile and lasting damage from chemotherapy.
What Nearly Brainless Rodents Know About Weight Loss and Hunger

2 weeks ago | nytimes.com | Gina Kolata

Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop. Do we really have free will when it comes to eating? It's a vexing question that is at the heart of why so many people find it so difficult to stick to a diet. To get answers, one neuroscientist, Harvey J. Grill of the University of Pennsylvania, turned to rats and asked what would happen if he removed all of their brains except their brainstems.
Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar

3 weeks ago | myheraldreview.com | Gina Kolata

A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning. The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected.
What to Know About Eli Lilly's Daily Pill for Weight Loss

3 weeks ago | nytimes.com | Rebecca Robbins |Gina Kolata

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes. Encouraging clinical trial results announced on Thursday stand to open up a huge market for a convenient daily pill to treat obesity and diabetes. The experimental drug, developed by Eli Lilly and known as orforglipron, is a type of medication known as a GLP-1.
Daily pill may work as well as Ozempic for weight loss and blood sugar

3 weeks ago | seattletimes.com | Gina Kolata

A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning. The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But GLP-1s are expensive, must be kept refrigerated and must be injected.